A malnourished 9-year-old boy was allegedly locked in his father's van in eastern France, found…
Breakthrough ALS study launches as drug aims to slow disease progression
The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.
Related Posts
